Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empirical Radioactive Iodine Therapy in TENIS Syndrome
NCT07453225Phase 2Not yet recruiting
- Sponsor
- Assiut University
- Start
- Apr 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of iodine-131 in differentiated thyroid cancer (DTC) (2 arms), sponsored by Assiut University. Primary endpoint: Efficacy of empirical radioactive iodine therapy at 2 years. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
iodine-131
03
Conditions
differentiated thyroid cancer (DTC)
Beyond the preview
Go deeper on NCT07453225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07453225.